| Dr Jon Dirk Van Roo, MD | |
|
700 S Park St, Suite A404, Madison, WI 53715-1830 | |
| (608) 258-6504 | |
| Not Available |
| Full Name | Dr Jon Dirk Van Roo |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 700 S Park St, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033384565 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 125051916 (Illinois) | Secondary |
| 207P00000X | Emergency Medicine | 53967-20 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jon Dirk Van Roo, MD 700 S Park St, Suite A404, Madison, WI 53715-1830 Ph: (608) 258-6504 | Dr Jon Dirk Van Roo, MD 700 S Park St, Suite A404, Madison, WI 53715-1830 Ph: (608) 258-6504 |
News Archive
iMDsoft®, a global leader in clinical information systems for perioperative, critical, and acute care, and Codonics of Middleburg Heights, OH, a leading provider of image distribution solutions for the medical industry, have announced an agreement that will complement iMDsoft's anesthesia solution with an innovative syringe labeling system. The system will be fully integrated with the MetaVision® Anesthesia Information Management System (AIMS).
In an attempt to address the anticipated primary care physician shortage, more and more medical schools are starting to recognize the correlation between an applicant's level of community service and the likelihood that candidate will pursue a career in underserved areas of medicine. As a result, volunteerism is expected to emerge as a critical component of an effective application in this year's admissions cycle, according to medical school admissions consulting firm Veritas Prep.
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV- (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years. INTUNIV, a once-daily formulation of guanfacine, is the first selective alpha-2A adrenergic receptor agonist approved for the treatment of ADHD.
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that it will commence a large internal clinical study for its Nucleosomics diagnostic products this month.
› Verified 5 days ago
Kendra L Fabian, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-262-2398 | |
Michael K Abernethy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-262-2398 Fax: 608-262-9999 | |
Kip A Kircher, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St Ste A404, Madison, WI 53715 Phone: 608-258-6504 | |
Dr. Joseph David Hansen, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 700 S Park St, Madison, WI 53715 Phone: 800-680-4369 | |
Milton H Johnson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 752 N High Point Rd, Madison, WI 53717 Phone: 608-824-4000 Fax: 608-824-4919 | |
Dr. Aaron Kraut, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-262-2398 |